Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biotricity Inc
(NQ:
BTCY
)
1.140
-0.040 (-3.39%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biotricity Inc
< Previous
1
2
3
4
5
6
7
Next >
The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO
August 26, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
COVID-19
Biotricity Announces Proposed Underwritten Public Offering of Common Stock in Connection with Expected Nasdaq Listing
August 25, 2021
REDWOOD CITY, CA / ACCESSWIRE / August 25, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it intends to offer shares of its...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Biotricity Reports 290% Revenue Growth Year Over Year in Record First Quarter
August 16, 2021
REDWOOD CITY, CA / ACCESSWIRE / August 16, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, is pleased to provide financial results for its fiscal...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Product Safety
Regulatory
Biotricity to Report First Quarter Fiscal 2022 Financial Results on August 16, 2021
August 12, 2021
REDWOOD CITY, CA / ACCESSWIRE / August 12, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it will release its financial...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Innovative Company Biotricity is Providing Solutions for Chronic Diseases
July 15, 2021
A new study revealed that 44% of older millennials that will soon hit 40 suffer at least one chronic health condition that takes a toll, both financially and emotionally —...
Via
Benzinga
Healthy Hearts and Healthy Wallets: Why one Healthtech Startup is a Must-Invest
July 14, 2021
Last month, we saw a lot of great startups at the Benzinga Global Small Cap Conference. Many of them screamed, “This is an innovation tech stock you need to buy now!...
Via
Benzinga
Biotricity's 2021 Fiscal Fourth Quarter Growth Trend Continues into Fiscal 2022
July 07, 2021
Fiscal Q1-22 to be the 9th quarter of growth and biggest quarter to date REDWOOD CITY, CA / ACCESSWIRE / July 7, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Why A Northstar Analyst Is Bullish On This Disruptive MedTech Company
July 01, 2021
A strong value proposition and high retention rate have turned Northland Capital Markets bullish on Biotricity, Inc (OTC:
Via
Benzinga
Biotricity Reports Record Quarterly and Annual Revenue for Fiscal 2021
June 15, 2021
REDWOOD CITY, CA / ACCESSWIRE / June 15, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, is pleased to provide unaudited, preliminary financial...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Biotricity to Report Fourth Quarter Fiscal 2021 and Financial Results on June 15, 2021
June 09, 2021
REDWOOD CITY, CA / ACCESSWIRE / June 9, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it will release its financial results...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Lasting Impact of Covid: Fewer Doctor's Office Visits Thanks to At-Home Diagnostics
June 02, 2021
While treatment has long been viewed as the central role of our healthcare system, the COVID-19 pandemic brought diagnostics to center stage. Early and accurate detection was...
Via
Benzinga
Exposures
COVID-19
Biotricity to Present at 2021 LD Micro Invitational XI
June 01, 2021
REDWOOD CITY, CA / ACCESSWIRE / June 1, 2021 / Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, announced today that its...
From
Biotricity, Inc.
Via
AccessWire
Biotricity Announces 2021 Uplisting Strategy to Major Exchange
May 25, 2021
REDWOOD CITY, CA / ACCESSWIRE / May 25, 2021 / Biotricity, Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is pleased to announce...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Biotricity to Present its Disruptive Medical Technologies at the Benzinga Global Small Cap Conference on May 14
May 14, 2021
Presentation to focus on flagship Bioflux® product for the multi-billion cardiac monitoring and diagnostic market REDWOOD CITY, CA / ACCESSWIRE / May 14, 2021 /Biotricity, Inc. (OTCQB:BTCY)...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Maxim Group Is Bullish About Biotricity Generating Over 100% Revenue Growth
May 06, 2021
Biotricity Inc (OTC: BTCY) has a multi-billion dollar target addressable market, which should expand as an ecosystem is created for solutions to chronic conditions, according to...
Via
Benzinga
Biotricity Selected as Finalist in Fast Company's 2021 World Changing Ideas Awards
May 04, 2021
REDWOOD CITY, CA / ACCESSWIRE / May 4, 2021 / Biotricity, Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is pleased to announce that...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Remote Monitoring Telemedicine Company Sees Spiked Growth Of Products And Technology
April 20, 2021
The following article is sponsored by Biotricity Inc. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its...
Via
Benzinga
Biotricity to Report Record Revenue Results for Fiscal 2021
April 14, 2021
Unaudited Financial Results Include Revenue Growth of 133% REDWOOD CITY, CA / ACCESSWIRE / April 14, 2021 / Biotricity, Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.